Science Explorer Back to mapMap
Discussion
Company · Vancouver · Canada

Zymeworks (Canada)

Research works
75
▲ 286% vs 2018-21
Citations
828
11.0 per fractional work
Top-10% rate
20.9%
all institutions 10.0%
Open access
29%
world 40%
International
22%
world 18%

Not ranked overall: Zymeworks (Canada) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Zymeworks (Canada) work in?

In 2022-now, 67% of research at Zymeworks (Canada) is in Health Sciences, 22% in Life Sciences. Its largest fields are Medicine (66%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (7%). It does 2.5× the world's share of Health Sciences.

Health Sciences: 35 fractional works · 67.0% of its workMedicine: 34 fractional works · 66.3% of its workOncology: 19 fractional works · 35.9% of its workRadiology, Nuclear Medicine and Imaging: 11 fractional works · 21.8% of its workPulmonary and Respiratory Medicine: 2 fractional works · 2.9% of its workSurgery: 1 fractional works · 2.0% of its workPhysiology: 0 fractional works · 0.9% of its workGenetics: 0 fractional works · 0.6% of its workInfectious Diseases: 0 fractional works · 0.6% of its workNephrology: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.4% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 0.6% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workHealth Information Management: 0 fractional works · 0.3% of its workLife Sciences: 11 fractional works · 21.9% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 14.1% of its workMolecular Biology: 6 fractional works · 11.2% of its workGenetics: 1 fractional works · 1.1% of its workBiotechnology: 0 fractional works · 1.0% of its workBiochemistry: 0 fractional works · 0.6% of its workCancer Research: 0 fractional works · 0.2% of its workImmunology and Microbiology: 3 fractional works · 6.6% of its workImmunology: 3 fractional works · 6.6% of its workAgricultural and Biological Sciences: 0 fractional works · 0.7% of its workSoil Science: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 0.5% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 6 fractional works · 10.7% of its workEngineering: 2 fractional works · 4.5% of its workBiomedical Engineering: 2 fractional works · 4.1% of its workAutomotive Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 2 fractional works · 3.6% of its workOrganic Chemistry: 2 fractional works · 3.6% of its workMaterials Science: 1 fractional works · 1.3% of its workPolymers and Plastics: 0 fractional works · 0.8% of its workBiomaterials: 0 fractional works · 0.5% of its workEnvironmental Science: 0 fractional works · 1.0% of its workEcology: 0 fractional works · 0.6% of its workPollution: 0 fractional works · 0.3% of its workComputer Science: 0 fractional works · 0.3% of its workArtificial Intelligence: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 0.3% of its workPolitical Science and International Relations: 0 fractional works · 0.3% of its workALL ITS WORKZymeworks(Canada)52fractional works, 2022-now
Life Sciences22%Physical Sciences11%Health Sciences67%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Medicine3466.3%
    2. Health Professions00.6%
    1. Biochemistry, Genetics and Molecular Biology714.1%
    2. Immunology and Microbiology36.6%
    3. Agricultural and Biological Sciences00.7%
    4. Neuroscience00.5%
    1. Engineering24.5%
    2. Chemistry23.6%
    3. Materials Science11.3%
    4. Environmental Science01.0%
    5. Computer Science00.3%
    1. Social Sciences00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Zymeworks (Canada) specialise in?

Where its research is concentrated relative to its size: Medicine takes 3.5× the share of its output that it takes of world research.

  1. MedicineField · 34.3 works3.5×
  2. Health SciencesDomain · 34.6 works2.9×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.15× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.65× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 6.60× its world share, 3 worksImmunology and Micro…Neuroscience: 0.30× its world share, 0 worksNeuroscienceChemistry: 2.30× its world share, 2 worksChemistryComputer Science: 0.04× its world share, 0 worksComputer ScienceEngineering: 0.30× its world share, 2 worksEngineeringEnvironmental Science: 0.19× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.37× its world share, 1 worksMaterials ScienceHealth Professions: 0.25× its world share, 0 worksHealth ProfessionsMedicine: 3.45× its world share, 34 worksMedicineSocial Sciences: 0.03× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.6×. Every wedge is a field page.

All 12 fields, with their numbers
  1. Immunology and Microbiology6.60×3 works
  2. Medicine3.45×34 works
  3. Biochemistry, Genetics and Molecular Biology2.65×7 works
  4. Chemistry2.30×2 works
  5. Materials Science0.37×1 works
  6. Neuroscience0.30×0 works
  7. Engineering0.30×2 works
  8. Health Professions0.25×0 works
  9. Environmental Science0.19×0 works
  10. Agricultural and Biological Sciences0.15×0 works
  11. Computer Science0.04×0 works
  12. Social Sciences0.03×0 works

Who are the top researchers at Zymeworks (Canada)?

Ranked on the quality score, Nichole K. Escalante, Jamie R. Rich and Grant Wickman lead among researchers whose main affiliation is Zymeworks (Canada).

  1. 1 Nichole K. Escalante Canada · #572,375 worldwide 1.2k citations · 26 works
  2. 2 Jamie R. Rich Canada · #616,843 worldwide 1.8k citations · 101 works
  3. 3 Grant Wickman Canada · #775,547 worldwide 2k citations · 61 works
  4. 4 Nicole J. Afacan Canada · #947,603 worldwide 667 citations · 16 works
  5. 5 Vincent Fung Canada · #1,029,419 worldwide 348 citations · 77 works
  6. 6 Maya C. Poffenberger Canada · #1,083,400 worldwide 2.3k citations · 27 works
  7. 7 Jodi Wong Canada · #1,195,871 worldwide 229 citations · 64 works
  8. 8 Andrea Hernández Rojas Canada · #1,248,713 worldwide 238 citations · 64 works
  9. 9 Chayne L. Piscitelli Canada · #1,332,020 worldwide 1.1k citations · 30 works
  10. 10 Raffaele Colombo Canada · #1,425,907 worldwide 1.1k citations · 119 works
All ranked researchers at Zymeworks (Canada)

What are the most cited papers from Zymeworks (Canada)?

The most cited paper from Zymeworks (Canada) is "Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study" (James J. Harding et al., 2023), with 282 citations. Next come "Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics" (231) and "The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development" (227).

Most cited papers
#PaperReleasedCitations
1 Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study James J. Harding et al. · The Lancet Oncology Open access 2 Jun 2023 282
2 Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics Richard S. Rogers, Nancy S. Nightlinger, Brittney Livingston et al. · mAbs Open access 17 Jul 2015 231
3 The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development Raffaele Colombo, Paolo Tarantino, Jamie R. Rich et al. · Cancer Discovery Open access 23 Oct 2024 227
4 Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study Funda Meric‐Bernstam et al. · The Lancet Oncology Open access 15 Nov 2022 198
5 The therapeutic window of antibody drug conjugates: A dogma in need of revision Raffaele Colombo, Jamie R. Rich · Cancer Cell Open access 13 Oct 2022 194
All 75 most cited papers, with filters and sorting

Which keywords describe research at Zymeworks (Canada)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Glycosylation, Breast Cancer, Monoclonal Antibodies, Fc Receptors, Therapeutic Antibodies, Receptor tyrosine kinases and HER2.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 31 words, with their numbers
  1. Chemotherapy12▲ 32×5 topics
  2. Glycosylation11▲ 191×2 topics
  3. Breast Cancer10▲ 80×2 topics
  4. Monoclonal Antibodies10▲ 225×2 topics
  5. Fc Receptors10▲ 361×1 topic
  6. Therapeutic Antibodies10▲ 284×1 topic
  7. Receptor tyrosine kinases10▲ 482×2 topics
  8. HER210▲ 580×1 topic
  9. Trastuzumab10▲ 370×1 topic
  10. Immunotherapy6▲ 17×7 topics
  11. Cancer Immunotherapy6▲ 77×2 topics
  12. Tumor Regression6▲ 99×2 topics
  13. CAR T Cells5▲ 143×1 topic
  14. Chimeric Antigen Receptor5▲ 143×1 topic
  15. Cancer2▲ 2.7×7 topics
  16. Inflammation2▲ 1.61×6 topics
  17. Nanolithography2▲ 274×1 topic
  18. Soft Lithography2▲ 274×1 topic
  19. Metastatic Breast Cancer2▲ 52×2 topics
  20. Targeted Therapy2▲ 13×4 topics
  21. Drug Discovery1▲ 12×2 topics
  22. Epidemiology1▼ 0.68×4 topics
  23. Treatment1▲ 1.86×2 topics
  24. Cancer Therapy1▲ 3.9×3 topics
  25. PET Imaging1▲ 12×2 topics
  26. Click Chemistry1▲ 36×1 topic
  27. Copper-Catalyzed Cycloaddition1▲ 71×1 topic
  28. Data Analysis1▲ 7.4×2 topics
  29. Gene Expression1▲ 3.1×2 topics
  30. Radioimmunotherapy1▲ 70×1 topic
  31. Radiopharmaceuticals1▲ 70×1 topic

Which research topics does Zymeworks (Canada) publish most on?

By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, CAR-T cell therapy research and Nanofabrication and Lithography Techniques.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 10 works
  2. 2 HER2/EGFR in Cancer Research Oncology 10 works
  3. 3 CAR-T cell therapy research Oncology 5 works
  4. 4 Nanofabrication and Lithography Techniques Biomedical Engineering 2 works
  5. 5 Click Chemistry and Applications Organic Chemistry 1 works
  6. 6 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
  7. 7 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  8. 8 Colorectal Cancer Treatments and Studies Oncology 1 works
  9. 9 IL-33, ST2, and ILC Pathways Immunology 1 works
  10. 10 Eosinophilic Esophagitis Surgery 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.3%not open70.7%

World: 40% of research is openly available.

with international co-authors22.5%domestic only77.5%

World: 18% is written across borders.

How has Zymeworks (Canada)'s research output changed?

Output in 2022-2025 was 286% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Zymeworks (Canada) as a percentage of every work published that year, 0.00014% in 2024.

still counting0.00020%0.00040%Zymeworks (Canada)0.00021% in 20251990200020102020

Fractional works of Zymeworks (Canada) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Vancouver

All research institutions in Vancouver

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Zymeworks (Canada). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.